These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 26438346)
21. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects. Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833 [TBL] [Abstract][Full Text] [Related]
22. Cognitive predictors of cognitive change following bilateral subthalamic nucleus deep brain stimulation in Parkinson's disease. Yágüez L; Costello A; Moriarty J; Hulse N; Selway R; Clough C; Samuel M; Ashkan K J Clin Neurosci; 2014 Mar; 21(3):445-50. PubMed ID: 24231557 [TBL] [Abstract][Full Text] [Related]
23. Change in fatigue after bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease. Chou KL; Persad CC; Patil PG Parkinsonism Relat Disord; 2012 Jun; 18(5):510-3. PubMed ID: 22341622 [TBL] [Abstract][Full Text] [Related]
24. Compensatory stepping in Parkinson's disease is still a problem after deep brain stimulation randomized to STN or GPi. St George RJ; Carlson-Kuhta P; King LA; Burchiel KJ; Horak FB J Neurophysiol; 2015 Sep; 114(3):1417-23. PubMed ID: 26108960 [TBL] [Abstract][Full Text] [Related]
25. Intraoperative MRI for optimizing electrode placement for deep brain stimulation of the subthalamic nucleus in Parkinson disease. Cui Z; Pan L; Song H; Xu X; Xu B; Yu X; Ling Z J Neurosurg; 2016 Jan; 124(1):62-9. PubMed ID: 26274983 [TBL] [Abstract][Full Text] [Related]
26. Emergence of restless legs syndrome after subthalamic stimulation in Parkinson's disease: a dopaminergic overstimulation? Marques A; Fantini ML; Morand D; Pereira B; Derost P; Ulla M; Debilly B; Lemaire JJ; Durif F Sleep Med; 2015 May; 16(5):583-8. PubMed ID: 25881920 [TBL] [Abstract][Full Text] [Related]
27. Subthalamic nucleus deep brain stimulation induces impulsive action when patients with Parkinson's disease act under speed pressure. Pote I; Torkamani M; Kefalopoulou ZM; Zrinzo L; Limousin-Dowsey P; Foltynie T; Speekenbrink M; Jahanshahi M Exp Brain Res; 2016 Jul; 234(7):1837-1848. PubMed ID: 26892884 [TBL] [Abstract][Full Text] [Related]
28. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease. Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564 [TBL] [Abstract][Full Text] [Related]
29. Surgical, medical, and hardware adverse events in a series of 141 patients undergoing subthalamic deep brain stimulation for Parkinson disease. Vergani F; Landi A; Pirillo D; Cilia R; Antonini A; Sganzerla EP World Neurosurg; 2010 Apr; 73(4):338-44. PubMed ID: 20849789 [TBL] [Abstract][Full Text] [Related]
30. Medication dose reductions after pallidal versus subthalamic stimulation in patients with Parkinson's disease. Evidente VG; Premkumar AP; Adler CH; Caviness JN; Driver-Dunckley E; Lyons MK Acta Neurol Scand; 2011 Sep; 124(3):211-4. PubMed ID: 20969559 [TBL] [Abstract][Full Text] [Related]
31. Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease. Lim SY; O'Sullivan SS; Kotschet K; Gallagher DA; Lacey C; Lawrence AD; Lees AJ; O'Sullivan DJ; Peppard RF; Rodrigues JP; Schrag A; Silberstein P; Tisch S; Evans AH J Clin Neurosci; 2009 Sep; 16(9):1148-52. PubMed ID: 19553125 [TBL] [Abstract][Full Text] [Related]
32. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213 [TBL] [Abstract][Full Text] [Related]
33. Associations between bilateral subthalamic nucleus deep brain stimulation (STN-DBS) and anxiety in Parkinson's disease patients: a controlled study. Chang C; Li N; Wu Y; Geng N; Ge S; Wang J; Wang X; Wang X J Neuropsychiatry Clin Neurosci; 2012; 24(3):316-25. PubMed ID: 23037645 [TBL] [Abstract][Full Text] [Related]
34. Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population? Derost PP; Ouchchane L; Morand D; Ulla M; Llorca PM; Barget M; Debilly B; Lemaire JJ; Durif F Neurology; 2007 Apr; 68(17):1345-55. PubMed ID: 17452578 [TBL] [Abstract][Full Text] [Related]
35. Pathological crying induced by deep brain stimulation of the subthalamic nucleus in Parkinson's disease. Wolf ME; Abdallat M; Blahak C; Krauss JK J Clin Neurosci; 2017 Nov; 45():159-161. PubMed ID: 28887071 [TBL] [Abstract][Full Text] [Related]
36. The impact of age and disease duration on the long term outcome of neurostimulation of the subthalamic nucleus. Shalash A; Alexoudi A; Knudsen K; Volkmann J; Mehdorn M; Deuschl G Parkinsonism Relat Disord; 2014 Jan; 20(1):47-52. PubMed ID: 24126022 [TBL] [Abstract][Full Text] [Related]
37. Changes in intracortical inhibition and clinical symptoms after STN-DBS in Parkinson's disease. Kobayashi M; Ohira T; Mihara B; Fujimaki T Clin Neurophysiol; 2016 Apr; 127(4):2031-7. PubMed ID: 26971486 [TBL] [Abstract][Full Text] [Related]
38. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial. Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021 [TBL] [Abstract][Full Text] [Related]
39. Medical therapy and subthalamic deep brain stimulation in advanced Parkinson's disease: a different long-term outcome? Merola A; Rizzi L; Zibetti M; Artusi CA; Montanaro E; Angrisano S; Lanotte M; Rizzone MG; Lopiano L J Neurol Neurosurg Psychiatry; 2014 May; 85(5):552-9. PubMed ID: 23847290 [TBL] [Abstract][Full Text] [Related]
40. The effects of unilateral versus bilateral subthalamic nucleus deep brain stimulation on prosaccades and antisaccades in Parkinson's disease. Goelz LC; David FJ; Sweeney JA; Vaillancourt DE; Poizner H; Metman LV; Corcos DM Exp Brain Res; 2017 Feb; 235(2):615-626. PubMed ID: 27844097 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]